‘Vaccine hesitancy’ among university students in Italy during the COVID-19 pandemic

AbstractThe debate around vaccines has been in the spotlight over the last few years in Europe, both within the scientific community and the general public debate. In this regard, the case of the Italian vaccination debate is particularly worrying given that Italy has been one of the European countries with the highest number of measles cases in the recent past. According to this scenario, we conducted a cross-sectional study on a convenience sample of Italian university students aimed at: (1) exploring their attitudes towards a future vaccine to prevent COVID-19 and; (2) evaluating the impact of the university curricula (healthcare vs. non-healthcare curricula) on the intention to vaccinate. Descriptive analysis on the 735 students that answered to the question on the intention to vaccinate showed that 633 (86.1%) students reported that they would choose to have a vaccination for the COVID-19 coronavirus; on the other side, 102 (13.9%) students reported that they would not or be not sure to vaccine (low intention to vaccinate). This means that in our sample more than one student out of 10 shows low intention to vaccinate (vaccine hesitancy). Furthermore, when running analysis comparing healthcare students versus non-healthcare students we found no significant differences in responses ’ percentage distribution (p = .097). Understanding the student’s perspective about the future COVID-19 vaccine and supporting their health engagement and consciousness...
Source: European Journal of Epidemiology - Category: Epidemiology Source Type: research

Related Links:

Getting the kids ready to go back to school each fall is stressful enough in a normal year, never mind in the midst of a pandemic. Between the more transmissible Delta coronavirus variant, rising cases across the country and new masking guidance from the U.S. Centers for Disease Control and Prevention (CDC), there’s a lot for parents to navigate as they plan for schools to reopen this August and September. On the whole, experts seem to agree it’s time to get kids back into their classrooms. Remote learning set many children—especially students of color—back academically, cut them off from essential ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
Emerg Med Clin North Am. 2021 Aug;39(3):453-465. doi: 10.1016/j.emc.2021.04.002. Epub 2021 Jun 10.ABSTRACTThe role of the emergency provider lies at the forefront of recognition and treatment of novel and re-emerging infectious diseases in children. Familiarity with disease presentations that might be considered rare, such as vaccine-preventable and non-endemic illnesses, is essential in identifying and controlling outbreaks. As we have seen thus far in the novel coronavirus pandemic, susceptibility, severity, transmission, and disease presentation can all have unique patterns in children. Emergency providers also have the...
Source: The Medical Clinics of North America - Category: General Medicine Authors: Source Type: research
Vaccine. 2021 Apr 27:S0264-410X(21)00509-0. doi: 10.1016/j.vaccine.2021.04.050. Online ahead of print.ABSTRACTIn 2020, the state of Texas implemented coronavirus disease 2019 (COVID-19) social distancing guidelines in order to prevent surges at Texas hospital emergency rooms and in intensive care units. As noted in other states, an unintended consequence of these activities was significant declines in childhood immunizations. After analyzing state-wide immunization register data for Texas, we observed a 47% relative decline in immunization rates between 2019 and 2020 among 5-month-olds and a 58% decline among 16-month-olds...
Source: Vaccine - Category: Allergy & Immunology Authors: Source Type: research
CONCLUSION: The COVID-19 pandemic could lead to health effects other than those directly attributable to the coronavirus itself. Renouncing care may result in healthcare delays highly deleterious for people and society. Public authorities are preoccupied with these questions; they have set up action plans aimed at encouraging patients to seek treatment without delay. That said, the COVID-19 pandemic crisis has also created opportunities, such as the expansion of telemedicine. Although partial, these indicators can provide useful information enabling public decision makers to be reactive and to implement specific actions to...
Source: Revue d Epidemiologie et de Sante Publique - Category: Epidemiology Authors: Source Type: research
More than 140 million Americans have gotten the COVID-19 vaccine. Health care and government leaders hope that tens of millions more will do so.One key to getting that many needles in that many arms may turn on the messaging used to persuade people that getting the vaccine is the right thing to do. As the country seeks to turn the page on the pandemic, two UCLA professors who specialize in the impact of messaging efforts — Hal Hershfield and Keith Holyoak — have identified opportunities and challenges on the road to herd immunity.In March of 2020, the World Health Organization declared the spread of the novel c...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news
Last March, friends and neighbors began stopping Emily Smith in her town outside of Waco, Texas, with questions about the coronavirus. An epidemiologist at Baylor University, Smith knows all too well how viruses are transmitted. But as the wife of a pastor and as a woman of faith, she also holds a trusted position in her community, and she would speak to those who asked about why she personally thought social distancing was a moral choice. As the weeks wore on, the questions kept coming: “What does flatten the curve mean?” “Is it safe for my child to kick a soccer ball outside with a friend?” So she...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized feature Magazine Misinformation & Disinformation Source Type: news
The current pandemic of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) highlights an urgent need to develop a safe, efficacious, and durable vaccine. Using a measles virus (rMeV) vaccine strain as the backbone, we developed a series of recombinant attenuated vaccine candidates expressing various forms of the...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Tags: Microbiology, Coronavirus (COVID-19) Biological Sciences Source Type: research
2021 got off to a grim pandemic start in the U.S. A huge surge in COVID-19 cases followed the holiday season, peaking at around 300,000 new cases on Jan. 8, 2020. More than 20,000 Americans lost their lives to the virus in a single week in January alone and over 146,00 in total have died since the start of the year. But six weeks later, the picture looks more promising. New daily cases have fallen sharply, daily deaths have fallen to levels not seen since Thanksgiving, and the pace of vaccine roll-out is speeding up. These positive trends mean that we can now begin to ask what the endgame might look like. Would we be happy...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
India’s COVID-19 vaccination scheme looked set for success. For the “pharmacy of the world,” which produced 60% of the vaccines for global use before the pandemic, supply was never going to be a problem. The country already had the world’s largest immunization program, delivering 390 million doses annually to protect against diseases like tuberculosis and measles, and an existing infrastructure that would make COVID-19 vaccine distribution easier. Ahead of the launch, the government organized dry runs, put up billboards touting the vaccines and replaced phone ringing tones with a message urging peo...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 feature India overnight Source Type: news
o In the race for a vaccine against SARS-CoV-2, the synthetic mRNA format has been shown to be the fastest one and proved to be safe and highly efficient, even at the very low dose of a few µg per injection. The mRNA vaccines are not new: vaccines that are based on attenuated mRNA viruses, such as Mumps, Measles, and Rubella, immunize by delivering their mRNAs into the cells of the vaccinated individual, who produces the viral proteins that then prime the immune response. Synthetic mRNA in liposomes can be seen as a modern, more refined, and thereby a safer version of those live attenuated RNA viruses. The anti-C...
Source: Viruses - Category: Virology Authors: Tags: Review Source Type: research
More News: Coronavirus | COVID-19 | Education | Epidemiology | Italy Health | Measles | Measles Vaccine | Pandemics | Psychology | Students | Study | Universities & Medical Training | Vaccines